Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments to Dissect the Contribution of IgE to Chronic Allergic Skin Inflammation
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary)
- Indications Atopic dermatitis
- Focus Pharmacodynamics
Most Recent Events
- 25 Jul 2014 New trial record